Alice Goodman

Read More ›

Atlanta, GA—Results of a recent study presented at the 2019 American College of Rheumatology Annual Meeting suggest that patients with young-onset and elderly-onset rheumatoid arthritis (RA) derive similar benefits from biologic disease-modifying antirheumatic drugs (bDMARDs). Regardless of age at disease onset, both groups of patients had similar clinical improvements with bDMARD therapy at 48 weeks, as well as similar maintenance and discontinuation rates as a result of adverse events. Read More ›

Atlanta, GA—Although immunotherapy with checkpoint inhibitors is an important advancement in the treatment of several types of cancer, clinicians have questioned whether patients with preexisting autoimmune disorders, such as rheumatoid arthritis (RA), can be safely treated with these agents. Results from a small, retrospective study, presented at the 2019 American College of Rheumatology Annual Meeting, suggest that they can. Read More ›

Atlanta, GA—New recommendations for the management of patients with gout were presented in draft form at the 2019 American College of Rheumatology (ACR) Annual Meeting. The ACR Practice Guidelines Committee determined that it was necessary to update the 2012 version of the guidelines, based on new evidence from clinical trials. The new guidelines are currently under peer review and the committee is hoping to have them published sometime in 2020. Read More ›

Atlanta, GA—Results of a clinical trial presented at the 2019 American College of Rheumatology Annual Meeting revealed a dramatic increase in opioid-use disorder (OUD) hospitalizations over the past 20 years in patients with rheumatic diseases, including gout, osteoarthritis, fibromyalgia, low back pain, and rheumatoid arthritis. Read More ›

The first randomized trial to compare robotic-assisted prostatectomy with conventional open radical prostatectomy found no meaningful differences between these techniques in urinary and sexual function or in the rate of positive surgical margins in men with localized prostate cancer in the first 12 weeks after surgery (Yaxley JW, et al. Lancet. Read More ›

The negative effects of smoking and obesity are present in both sexes, but were more robust in women according to the results of a study presented at the 2016 European League Against Rheumatism Annual Congress. Read More ›

Researchers have defined an 81-feature molecular signature to identify neuroendocrine prostate cancer—an aggressive and rapidly progressing type of prostate cancer that is increasingly being recognized in patients with advanced disease and signals poor overall survival. Read More ›

Significant cost-savings in treating patients with prostate cancer could be achieved in the US healthcare system with the use of the cell-cycle progression (CCP) gene-expression assay called Prolaris. Read More ›

At most hospitals and other inpatient facilities, procedures are in place for identifying patients at risk of falling, and there are guidelines for the prevention of falls. Read More ›

Cancer patients are often at risk for impaired fertility related to their treatments. Read More ›

A nurse-led interdisciplinary symptom management team has been implemented at the Billings Clinic Cancer Center in Montana, part of a top 100 hospital, according to Truven Health Analytics. Read More ›

Oral chemotherapy presents unique issues, including safety and toxicity, and advance planning is essential. Read More ›